Headache and Dizziness as Prevailing Clinical Manifestations in Parkinson's Patients Following COVID-19 DOI Open Access
Mohammad Haddadi,

Yasamin Meamarzadegan,

Ali Vasheghani Farahani

et al.

Archives of Neuroscience, Journal Year: 2024, Volume and Issue: 11(3)

Published: June 12, 2024

Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has posed significant global health challenges, particularly for vulnerable populations. Objectives: This retrospective report from the Iranian Network Research in Viral Diseases (INRVD) investigates common clinical symptoms of COVID-19 individuals with Parkinson's (PD). suggests neurological complications can occur during SARS-CoV-2 infection, but there are limited studies on PD patients COVID-19. Given probable heightened vulnerability patients, evaluating symptoms, especially manifestations, is crucial. Methods: Data 54 were collected INRVD March 2020 to May 2021. Nasal, oropharyngeal, and nasopharyngeal swabs presenting following CDC guidelines. Following sample collection, RT-PCR assays performed confirmation. Statistical analysis was conducted using Chi-square test Fisher's exact test. Results: Among included study, 27 tested positive Of subjects analyzed, 38.9% female 61.1% male. Comparison revealed a higher rate sore throat (74%) shortness breath (81%) group as disease. Interestingly, rates dizziness (67%) headache observed Conclusions: study enhances our understanding diverse manifestations its impact underlying conditions such PD. increased prevalence among underscores need further investigation clarify whether these directly result infection or if they may also be influenced itself treatment. It important consider that while attributed disorder linked medication medical interventions, typically associated

Language: Английский

Headache and Dizziness as Prevailing Clinical Manifestations in Parkinson's Patients Following COVID-19 DOI Open Access
Mohammad Haddadi,

Yasamin Meamarzadegan,

Ali Vasheghani Farahani

et al.

Archives of Neuroscience, Journal Year: 2024, Volume and Issue: 11(3)

Published: June 12, 2024

Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has posed significant global health challenges, particularly for vulnerable populations. Objectives: This retrospective report from the Iranian Network Research in Viral Diseases (INRVD) investigates common clinical symptoms of COVID-19 individuals with Parkinson's (PD). suggests neurological complications can occur during SARS-CoV-2 infection, but there are limited studies on PD patients COVID-19. Given probable heightened vulnerability patients, evaluating symptoms, especially manifestations, is crucial. Methods: Data 54 were collected INRVD March 2020 to May 2021. Nasal, oropharyngeal, and nasopharyngeal swabs presenting following CDC guidelines. Following sample collection, RT-PCR assays performed confirmation. Statistical analysis was conducted using Chi-square test Fisher's exact test. Results: Among included study, 27 tested positive Of subjects analyzed, 38.9% female 61.1% male. Comparison revealed a higher rate sore throat (74%) shortness breath (81%) group as disease. Interestingly, rates dizziness (67%) headache observed Conclusions: study enhances our understanding diverse manifestations its impact underlying conditions such PD. increased prevalence among underscores need further investigation clarify whether these directly result infection or if they may also be influenced itself treatment. It important consider that while attributed disorder linked medication medical interventions, typically associated

Language: Английский

Citations

0